D N Brindley Selected Research

S 15261

11/2000

Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D N Brindley Research Topics

Disease

3	Obesity 01/2003 - 11/2000
3	Insulin Resistance 01/2003 - 11/2000
1	Neoplasms (Cancer) 02/2009
1	Breast Neoplasms (Breast Cancer) 02/2009
1	Melanoma (Melanoma, Malignant) 02/2009
1	Necrosis 01/2003
1	Atherosclerosis 03/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2000
1	Body Weight (Weight, Body) 11/2000

Drug/Important Bio-Agent (IBA)

2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003 - 01/2001
2	CeramidesIBA 01/2003 - 01/2001
2	Glucose (Dextrose)FDA LinkGeneric 01/2003 - 01/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2002
1	LipidsIBA 03/2002
1	Triglycerides (Triacylglycerol)IBA 03/2002
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2001
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2001
1	S 15261IBA 11/2000
1	Insulin (Novolin)FDA Link 11/2000
1	Metformin (Glucophage)FDA LinkGeneric 11/2000
1	Troglitazone (Rezulin)FDA Link 11/2000